Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Dennis Burton and Andrew Ward.
Connection Strength

1.488
  1. Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization. Sci Adv. 2021 07; 7(31).
    View in: PubMed
    Score: 0.240
  2. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Cell Rep. 2018 01 23; 22(4):1103.
    View in: PubMed
    Score: 0.188
  3. Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model. Cell Rep. 2017 Oct 03; 21(1):222-235.
    View in: PubMed
    Score: 0.184
  4. Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches. Immunity. 2017 06 20; 46(6):1073-1088.e6.
    View in: PubMed
    Score: 0.180
  5. A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic ß-Hairpin Structure. Immunity. 2017 04 18; 46(4):690-702.
    View in: PubMed
    Score: 0.178
  6. Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science. 2021 08 13; 373(6556):818-823.
    View in: PubMed
    Score: 0.059
  7. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun. 2021 05 19; 12(1):2938.
    View in: PubMed
    Score: 0.059
  8. A combination of cross-neutralizing antibodies synergizes to prevent SARS-CoV-2 and SARS-CoV pseudovirus infection. Cell Host Microbe. 2021 05 12; 29(5):806-818.e6.
    View in: PubMed
    Score: 0.059
  9. A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody. PLoS Pathog. 2020 12; 16(12):e1009089.
    View in: PubMed
    Score: 0.057
  10. HIV-1 vaccine design through minimizing envelope metastability. Sci Adv. 2018 11; 4(11):eaau6769.
    View in: PubMed
    Score: 0.050
  11. Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer. Nat Commun. 2018 09 12; 9(1):3693.
    View in: PubMed
    Score: 0.049
  12. Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization. Immunity. 2018 08 21; 49(2):288-300.e8.
    View in: PubMed
    Score: 0.049
  13. Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding. Nat Commun. 2017 11 21; 8(1):1655.
    View in: PubMed
    Score: 0.046
  14. Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer. Front Immunol. 2017; 8:1025.
    View in: PubMed
    Score: 0.046
  15. Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape. PLoS Pathog. 2017 01; 13(1):e1006074.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.